Age Related Macular Degeneration

Posted by in Blog | 2,036 comments

with Dr. Raphael Rosenbaum

Age Related Macular Degeneration

.

.

We all have heard about Lucentis, Avastin, Macugen and Regeneron’s
VEGF-Trap for the treatment of the Wet form of Age related macular
degeneration.

But whats the future for Dry AMD.

The government is currently conducting the AREDS 2 study that is investigating the use of Vitamin C, Vitamin E, Beta-carotene, Zinc, Copper, lutein, zeaxanthin, and omega-3 fatty acids for dry AMD.  Anecdotal studies have shown a benefit in patients who use these medications.  Other studies in the past 5 years have indicated that patients on long term anti-inflammatory therapy like oral NSAIDs have a lower progression rate of dry AMD.  Over the past year studies have indicated that statin therapy for elevated cholesteral may slow the progression of Dry AMD. Most recently studies have shown that women who live a healthy active lifestyle and refrain from smoking have a lower incidence of progression of dry AMD.  Based on these findings one may consider prescribing low dose chronic oral NSAIDs, using Statins, and encouraging a healthy lifestyles in an effort to slow the progression of dry AMD.

Leave a Reply